Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05239598 · ClinicalTrials.gov registry record · Phase 2
Povidone-Iodine Oral Rinse Study
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT05239598: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT05239598 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05239598, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is a two-arm, randomized, 2-phase study. Phase I will be double blinded clinical trial of the safety and efficacy of an antiseptic mouthwash solution on reducing SARS-CoV-2 load in COVID 19+ adult individuals. Phase II is designed as an open label trial, and all subjects will receive the active mouthwash.
Interventions
- DRUG Mouth rinse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-02-07 |
| Est. Completion | 2022-07-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05239598
The ClinicalTrials.gov registry entry for NCT05239598 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mouth rinse is the first listed.
NCT05239598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05239598 about?
NCT05239598 is a clinical study titled "Povidone-Iodine Oral Rinse Study". This study is a two-arm, randomized, 2-phase study. Phase I will be double blinded clinical trial of the safety and efficacy of an antiseptic mouthwash solution on reducing SARS-CoV-2 load in COVID 19+ adult individuals. Phase II is designed as an open label trial, and all subjects will receive the ...
What is the current status of trial NCT05239598?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2022-02-07. Estimated completion is 2022-07-13.
What interventions are being tested in trial NCT05239598?
The interventions under investigation include: Mouth rinse (DRUG).
Who is sponsoring clinical trial NCT05239598?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.